NCT01155427
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
Not specified
Clinical trial condition
Hepatitis B, Chronic
Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.
532 public trials
70 recruiting studies
Hepatitis B, Chronic trial results
NCT00226382
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong SAR, China
NCT01107483
- Conditions
- Bacteremia, Blood-Borne Infections, Chronic Disease, +20 more
- Locations
-
- The Third Affliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT01022801
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
Not specified
Completed
Continue Entecavir Rollover From China
NCT00975091
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus, +15 more
- Locations
-
Not specified
Completed
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00324961
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Wuhan, Hubei, China
- GSK Investigational Site Nanjing, Jiangsu, China
Completed
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients
NCT00441974
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Wuhan, Hubei, China
- GSK Investigational Site Nanjing, Jiangsu, China
NCT00316719
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
Not specified
Completed
Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B
NCT00895596
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Queen Mary Hospital Hong Kong, China
- Korea University Medical Center Seoul, South Korea
- Severance Hospital of Yonsei University Seoul, South Korea
- The Catholic University of Korea, Kangnam St. Mary's Hospital Seoul, South Korea
NCT00895713
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
- Locations
-
- Cisanello Hospital. (University of Pisa). Pisa, Italy
- Ospedaliera Molinette Torino, Italy